The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Self-citationDiabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 2×
“gest a protective effect on cancer outcomes for metformin [60–63] but on the other hand, a potential increased cancer risk associated with exogenous insulin [61, 63–65], insulin”
BackgroundGiovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Immortal Time Bias in Pharmacoepidemiology
Suissa, S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm324 · Cited by 1,708
Lazcano-Ponce, E. C. (2009) · Salud Pública de México · Cited by 1,669
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124 · cited 2×
“analogues [65, 66] and sulfonylurea therapies [61, 63, 64].”
BackgroundType-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Glycemic index, glycemic load, and chronic disease risk—a meta-analysis of observational studies
Barclay, A. W., Petocz, P., McMillan-Price, J., Flood, V. M., Prvan, T., Mitchell, P., & Brand-Miller, J. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.627 · Cited by 1,061 · cited 1×
“Furthermore, poor dietary habits and physical inactivity are potentially important confounding factors to be considered, as they are thought to mediate cancer risk via insulin resistance and obesity [48, 49].”
BackgroundMetformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis
Larsson, S. C., Orsini, N., & Wolk, A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji375 · Cited by 1,038
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 988
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
Elashoff, M., Matveyenko, A. V., Gier, B., Elashoff, R., & Butler, P. C. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.018 · Cited by 944
Bowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1558 · Cited by 933
Self-citationMetformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Tabák, A. G., Jokela, M., Akbaraly, T. N., Brunner, E. J., Kivimäki, M., & Witte, D. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60619-x · Cited by 898
Self-citationDiabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 875
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Tobacco smoking and cancer: a brief review of recent epidemiological evidence
Sasco, A. J., Secretan, M. B., & Straif, K. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.07.998 · Cited by 804
Obesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone
Lewis, J. D., Ferrara, A., Peng, T., Hedderson, M., Bilker, W. B., Quesenberry, C. P., Vaughn, D. J., Nessel, L., Selby, J., & Strom, B. L. (2011) · Diabetes Care · doi:10.2337/dc10-1068 · Cited by 625
Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
Friberg, E., Orsini, N., Mantzoros, C. S., & Wolk, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0681-5 · Cited by 562
Pischon, T., Lahmann, P. H., Boeing, H., Friedenreich, C., Norat, T., Tjønneland, A., Halkjaer, J., Overvad, K., Clavel-Chapelon, F., Boutron-Ruault, M.-C., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj246 · Cited by 554
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Kasper, J. S., & Giovannucci, E. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0410 · Cited by 491
Wei, M., Gaskill, S. P., Haffner, S. M., & Stern, M. P. (1997) · Obesity Research · doi:10.1002/j.1550-8528.1997.tb00278.x · Cited by 481
Jonasson, J. M., Ljung, R., Talbäck, M., Haglund, B., Gudbjörnsdòttir, S., & Steineck, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1444-2 · Cited by 412
SDRN Epidemiology Group, & Colhoun, H. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1453-1 · Cited by 393
Assessment and Control for Confounding by Indication in Observational Studies
Psaty, B. M., Koepsell, T. D., Lin, D., Weiss, N. S., Siscovick, D. S., Rosendaal, F. R., Pahor, M., & Furberg, C. D. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb01603.x · Cited by 363
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
Yang, Y., Hennessy, S., & Lewis, J. D. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.011 · Cited by 350
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study
Gastaldelli, A., Ferrannini, E., Miyazaki, Y., Matsuda, M., & DeFronzo, R. A. (2004) · Diabetologia · doi:10.1007/s00125-003-1263-9 · Cited by 338
Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
Govindarajan, R., Ratnasinghe, L., Simmons, D. L., Siegel, E. R., Midathada, M. V., Kim, L., Kim, P. J., Owens, R. J., & Lang, N. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2777 · Cited by 336
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Pisani, P. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801954451 · Cited by 329
Does diabetes therapy influence the risk of cancer?
Smith, U., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1441-5 · Cited by 316
Diabetes mellitus and risk of bladder cancer: a meta-analysis
Larsson, S. C., Orsini, N., Brismar, K., & Wolk, A. (2006) · Diabetologia · doi:10.1007/s00125-006-0468-0 · Cited by 304
Davidson, L. E., Hudson, R., Kilpatrick, K., Kuk, J. L., McMillan, K., Janiszewski, P. M., Lee, S., Lam, M., & Ross, R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.558 · Cited by 297
Zendehdel, K. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg105 · Cited by 280
Golder, S., Loke, Y. K., & Bland, M. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001026 · Cited by 269
Park, S. M., Lim, M. K., Shin, S. A., & Yun, Y. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0243 · Cited by 263
Stocks, T., Rapp, K., Bjørge, T., Manjer, J., Ulmer, H., Selmer, R., Lukanova, A., Johansen, D., Concin, H., Tretli, S., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000201 · Cited by 243
Vella, V. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.245 · Cited by 239
Algire, C., Amrein, L., Zakikhani, M., Panasci, L., & Pollak, M. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-09-0252 · Cited by 234
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies
Papanikolaou, P. N. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050873 · Cited by 229
Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study
Swerdlow, A. J., Laing, S. P., Qiao, Z., Slater, S. D., Burden, A. C., Botha, J. L., Waugh, N. R., Morris, A. D., Gatling, W., Gale, E. A., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602611 · Cited by 190
Schienkiewitz, A., Schulze, M. B., Hoffmann, K., Kroke, A., & Boeing, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.2.427 · Cited by 187
Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies
Larsson, S. C., & Wolk, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2051-6 · Cited by 182
for the ADOPT Study Group and the RECORD Steering Committee, Home, P. D., Kahn, S. E., Jones, N. P., Noronha, D., Beck-Nielsen, H., & Viberti, G. (2010) · Diabetologia · doi:10.1007/s00125-010-1804-y · Cited by 177
Johnson, J. A., Bowker, S. L., Richardson, K., & Marra, C. A. (2011) · Diabetologia · doi:10.1007/s00125-011-2242-1 · Cited by 167
Self-citationIntensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
Johnson, J. A., & Bowker, S. L. (2010) · Diabetologia · doi:10.1007/s00125-010-1933-3 · Cited by 157
Self-citationEpidemiological aspects of neoplasms in diabetes
Nicolucci, A. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0187-3 · Cited by 156
Vandenbroucke, J. P., & Psaty, B. M. (2008) · JAMA · doi:10.1001/jama.2008.723 · Cited by 156
Insulin glargine and malignancy: an unwarranted alarm
Pocock, S., & Smeeth, L. L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61307-6 · Cited by 150
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
Home, P., & Lagarenne, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1530-5 · Cited by 144
Diabetes and Risk of Non-Hodgkin's Lymphoma
Mitri, J., Castillo, J. J., & Pittas, A. G. (2008) · Diabetes Care · doi:10.2337/dc08-1034 · Cited by 142
Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
Renehan, A. G., Yeh, H., Johnson, J. A., Wild, S. H., Gale, E. A. M., & Møller, H. (2012) · Diabetologia · doi:10.1007/s00125-012-2526-0 · Cited by 137
Self-citationSubstantially increased risk of cancer in patients with diabetes mellitus
Noto, H., Osame, K., Sasazuki, T., & Noda, M. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.06.004 · Cited by 136
Cancer and diabetes ‐ a follow‐up study of two populationbased cohorts of diabetic patients
Hjalgrim, H., Frisch, M., Ekbom, A., Kyvik, K. O., Melbye, M., & Green, A. (1997) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1997.tb00004.x · Cited by 127
Shu, X., Ji, J., Li, X., Sundquist, J., Sundquist, K., & Hemminki, K. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03011.x · Cited by 125
Meza, R., Jeon, J., Renehan, A. G., & Luebeck, E. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4417 · Cited by 122
Self-citationDoses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Mannucci, E., Monami, M., Balzi, D., Cresci, B., Pala, L., Melani, C., Lamanna, C., Bracali, I., Bigiarini, M., Barchielli, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0476 · Cited by 121
Dejgaard, A., Lynggaard, H., Råstam, J., & Thomsen, M. (2009) · Diabetologia · doi:10.1007/s00125-009-1568-4 · Cited by 114
Diabetes and the Risk of Lung Cancer
Hall, G. C., Roberts, C. M., Boulis, M., Mo, J., & MacRae, K. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.590 · Cited by 101
Impact of Fasting Plasma Glucose Levels on Gastric Cancer Incidence in a General Japanese Population
Yamagata, H., Kiyohara, Y., Nakamura, S., Kubo, M., Tanizaki, Y., Matsumoto, T., Tanaka, K., Kato, I., Shirota, T., & Iida, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.789 · Cited by 100
Goodwin, P. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7132 · Cited by 76
Johnson, J. A., & Gale, E. A. (2010) · Diabetes · doi:10.2337/db10-0334 · Cited by 65
Self-citationBariatric surgery, weight reduction, and cancer prevention
Renehan, A. G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70170-6 · Cited by 58
Self-citationDoes Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?
Gerstein, H. C. (2010) · JAMA · doi:10.1001/jama.2010.60 · Cited by 58
Gastaldelli, A., Ferrannini, E., Miyazaki, Y., Matsuda, M., & DeFronzo, R. A. (2004) · Diabetologia · doi:10.1007/s00125-004-1479-3 · Cited by 52
Tannock, I. F., & Kopelian, I. I. (1986) · PubMed · Cited by 48
Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes
Johnson, J. A., & Pollak, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1855-0 · Cited by 48
Self-citationInsulin Glargine and Cancer—An Unsubstantiated Allegation
Garg, S. K., Hirsch, I. B., & Skyler, J. S. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.1705 · Cited by 47
Do cancer cells care if their host is hungry?
Pollak, M. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.04.006 · Cited by 38
Diabetes mellitus and ovarian cancer (Sweden)
Weiderpass, E., Ye, W., Vainio, H., Kaaks, R., & Adami, H. (2002) · Cancer Causes & Control · doi:10.1023/a:1020271000069 · Cited by 36
Insulin glargine and cancer: another side to the story?
Gale, E. A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61477-x · Cited by 25
Metformin, Cancer, Alphabet Soup, and the Role of Epidemiology in Etiologic Research
Duncan, B. B., & Schmidt, M. I. (2009) · Diabetes Care · doi:10.2337/dc09-1183 · Cited by 24
Clark, A. M., Raine, K. D., & Raphael, D. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.3024 · Cited by 22
Why Do People With Diabetes Die Too Soon?
Rewers, M. (2008) · Diabetes Care · doi:10.2337/dc08-0245 · Cited by 17
Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations
Johnson, J. A., & Yasui, Y. (2010) · Diabetologia · doi:10.1007/s00125-010-1780-2 · Cited by 9
Self-citation
Cited by
Shared Risk Factors in Cardiovascular Disease and Cancer
Koene, R. J., Prizment, A. E., Blaes, A., & Konety, S. H. (2016) · Circulation · doi:10.1161/circulationaha.115.020406 · Cited by 1,494
The burden and risks of emerging complications of diabetes mellitus
Tomic, D., Shaw, J. E., & Magliano, D. J. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00690-7 · Cited by 1,163
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 860
Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
Lega, I. C., & Lipscombe, L. L. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz014 · Cited by 364
Self-citationHyperglycemia as a Risk Factor for Cancer Progression
Ryu, T. Y., Park, J., & Scherer, P. E. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.5.330 · Cited by 331
Metadata
- Authors
- on behalf of the Diabetes and Cancer Research Consortium, Johnson, J. A., Carstensen, B., Witte, D., Bowker, S. L., Lipscombe, L., & Renehan, A. G.
- Venue
- Diabetologia
- Published
- 2012-04-04
- Volume
- 55
- Issue
- 6
- Pages
- 1607-1618
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2044461008
- Cited by
- 260
- References
- 88
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.